Gleevec News
FDA Approves Gleevec for Children with Acute Lymphoblastic Leukemia
January 25, 2013 – The U.S. Food and Drug Administration today approved a new use of Gleevec (imatinib) to treat children newly diagnosed with Philadelphia chromosome positive (Ph+) acute...
FDA Approves Gleevec for Expanded Use in Patients with Rare Gastrointestinal Cancer
The U.S. Food and Drug Administration today granted Gleevec (imatinib) regular approval for use in adult patients following surgical removal of CD117-positive gastrointestinal stromal tumors (GIST)....
FDA Medwatch Alert: Gleevec (imatinib mesylate)
[Posted 10/19/2006] Novartis and FDA notified healthcare professionals about revisions to the PRECAUTIONS section of the prescribing information, describing the occasional occurrence of severe...
Ask a Question
Want to post your own question to this support group? You'll need to first create an account with Drugs.com (or sign in to your existing account).
Further Information
Related Condition Support Groups
Chronic Myelogenous Leukemia (CML), Acute Lymphoblastic Leukemia